PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Learning Labs are a fast growing EdTech startup focussed on helping people to learn languages across 3 core channels. They have launched unique language Post-it Notes, a digital language learning platform and have been licensed to over 15k pupils across schools in the UK.
days to go:
Expired
investment:
£577,007
Founded in 2015, Developing Experts is a complete online curriculum solution for children aged between the age group of 4 to 14 years. Developing Experts provides over 700 online lessons with a practical investigation, easy-to-understand handouts, interactive assessments and quizzes for multiple curricula including the National Curriculum. Additionally, with an aim to enhance child’s critical thinking and learning outcomes, it provides specialised lessons held by experts from the university and industry, specifically operational in science field.
days to go:
Expired
investment:
Withheld
Spearhead provide over 250 high quality, practical, training courses via their network of experienced trainers and their new online training platform. Spearhead have secured large corporate clients nationally, from various sectors.
days to go:
Expired
investment:
£140,660
Teaching children the value of cash in a cashless society. gohenry aims to communicate to children between the ages of 6-18 how to earn, spend, save and learn in a digital banking world. The company has more than 550k active members across the UK and the US and generated revenues of £6.1m in 2017 with a YoY growth of 115%. The main source of revenue is a membership fee charged monthly to parents for activating a child bank account.
days to go:
Expired
investment:
£6,000,000
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
Amino focuses on targeted nutrition using amino acids to improve human health, emphasizing the untapped potential beyond sports and bodybuilding. Currently offering pre- and intra-workout amino acid drinks, the company aims to expand its product line to cater to a broader consumer base, believing the market lacks variety in ready-to-mix powdered blends. Backed by scientific research and a commitment to taste and accessibility, Amino aspires to emerge as the leading global brand in amino acid products.
days to go:
Expired
investment:
£193,219
Role Models (RM) is a global education provider that seeks to complement traditional academic education with programmes that promote social and emotional wellbeing and dynamic thinking through a focus on leadership, resilience, creativity and collaboration. RM's online and offline courses focus on 3-15-year-olds. RM has scored average parent reviews of at least 4.8/5 on Outschool and aims to become a contender in the estimated £75 billion private tuition market that is forecast to grow to £139 billion by 2026. The company asserts that it is delivering courses in Saudi Arabia and China. RM has enrolled clients across 37 countries, developed a partner programme with JP Morgan, Morgan Stanley, Rothschild, Citibank and more to deliver courses to their employees, and generated revenue worth £2.4 million to date. The company will use the investment for marketing, technology and curriculum development.
days to go:
Expired
investment:
£711,728
